5 Best High Tech Stocks To Watch Right Now

DELAFIELD, Wis. (Stockpickr) — Trading stocks that trigger major breakouts can lead to massive profits. Once a stock trends to a new high, or takes out a prior overhead resistance point, then it’s free to find new buyers and momentum players that can ultimately push the stock significantly higher.

One example of a successful breakout trade I flagged recently was trucking player YRC Worldwide (YRCW), which I featured in Dec. 12’s “5 Stocks Under $10 Set to Soar” at $9.71 share. I mentioned in that piece that shares of YRCW had recently formed a triple bottom chart pattern at $7.06, $7.20 and $7.44 a share. Following that bottom, shares of YRCW were starting to reverse its downtrend and enter a new uptrend, since the stock was moving higher from its low of $7.06 to its recent high of $10.50 a share That move was quickly pushing shares of YRCW within range of triggering a major breakout trade above some near-term overhead resistance levels at $10.63 to $10.87 a share.

Guess what happened? Shares of YRCW triggered that breakout the following trading session with monster upside volume. This stock has continued to uptrend and soar higher since taking out those key resistance levels with bullish upside volume flows. Shares of YRCW tagged a recent high on Dec. 23 of $20.58 a share. That represents a massive gain of over 100% in just a few weeks for anyone who bought this breakout. As you can see, trading breakouts that trigger with strong volume can produce monster profits in very short timeframes.

5 Best High Tech Stocks To Watch Right Now: Lockheed Martin Corporation(LMT)

Lockheed Martin Corporation engages in the research, design, development, manufacture, integration, operation, and sustainment of advanced technology systems and products in the areas of defense, space, intelligence, homeland security, and government information technology in the United States and internationally. It also provides management, engineering, technical, scientific, logistic, and information services. The company operates in four segments: Aeronautics, Electronic Systems, Information Systems & Global Services (IS&GS), and Space Systems. The Aeronautics segment offers military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. Its products and programs comprise the F-35 multi-role, stealth fighter; the F-22 air dominance and multi-mission stealth fighter; the F-16 multi-role fighter; the C-130J tactical transport aircraft; and the C-5M strategic airlifter modernization program; and support for the P-3 maritime patrol aircraft, and the U-2 high-altitude reconnaissance aircraft. The Electronic Systems segment provides air and missile defense; tactical missiles; weapon fire control systems; surface ship and submarine combat systems; anti-submarine and undersea warfare systems; land, sea-based, and airborne radars; surveillance and reconnaissance systems; simulation and training systems; and integrated logistics and sustainment services. The IS&GS segment offers information technology solutions and advanced technology primarily in the areas of software and systems integration for space, air, and ground systems to various defense and civil government agencies. The Space Systems segment provides government and commercial satellites; strategic and defensive missile systems, including missile defense technologies and systems, and fleet ballistic missiles; and space transportation systems. Lockheed Martin Corporation was founded in 1909 and is based in Bethesda, Maryland.

Advisors’ Opinion:

  • [By Rich Smith]

    In contrast, the plane that’s meant to replace the A-10 — and many other weapons platforms besides — is Lockheed Martin’s (NYSE: LMT  ) F-35. Mother Jones mocks the F-35 as “a gold-plated aircraft” that’s “supposed to be an air fighter and a ground attack plane, but doesn’t perform particularly well at either task.”

  • [By Dividends4Life]

    Fair Value: In calculating fair value, I consider the NPV MMA Differential Fair Value along with these four calculations of fair value, see page 2 of the linked PDF for a detailed description: 1. Avg. High Yield Price 2. 20-Year DCF Price 3. Avg. P/E Price 4. Graham Number CINF is trading at a discount to only 3.) above. The stock is trading at a 36.8% premium to its calculated fair value of $34.96. CINF did not earn any Stars in this section. Dividend Analytical Data: In this section there are three possible Stars and three key metrics, see page 2 of the linked PDF for a detailed description: 1. Free Cash Flow Payout 2. Debt To Total Capital 3. Key Metrics 4. Dividend Growth Rate 5. Years of Div. Growth 6. Rolling 4-yr Div. > 15% CINF earned two Stars in this section for 1.) and 2.) above. A Star was earned since the Free Cash Flow payout ratio was less than 60% and there were no negative Free Cash Flows over the last 10 years. The stock earned a Star as a result of its most recent Debt to Total Capital being less than 45%. The company has paid a cash dividend to shareholders every year since 1954 and has increased its dividend payments for 54 consecutive years. Dividend Income vs. MMA: Why would you assume the equity risk and invest in a dividend stock if you could earn a better return in a much less risky money market account (MMA) or Treasury bond? This section compares the earning ability of this stock with a high yield MMA. Two items are considered in this section, see page 2 of the linked PDF for a detailed description: 1. NPV MMA Diff. 2. Years to > MMA The NPV MMA Diff. of the $62 is below the $500 target I look for in a stock that has increased dividends as long as CINF has. If CINF grows its dividend at 1.2% per year, it will take 5 years to equal a MMA yielding an estimated 20-year average rate of 3.68%. Memberships and Peers: CINF is a member of the S&P 500, a Dividend Aristocrat, a member of the Broad Dividend Achievers™ Index and a Divid

5 Best High Tech Stocks To Watch Right Now: Arrow Financial Corporation (AROW)

Arrow Financial Corporation operates as the holding company for Glens Falls National Bank and Trust Company, and Saratoga National Bank and Trust Company that offer various commercial and consumer banking, and financial products in the United States. The company offers various deposit products, which include demand deposits, savings, NOW, and money market deposits. It engages in a range of lending activities, including commercial and industrial lending primarily to small and midsized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. Arrow Financial Corporation maintains an indirect lending program through sponsorship of automobile dealer programs under which, it purchases dealer paper primarily from dealers that meet pre-established specifications. The company, through its trust operations, provides retirement planning, trust, and estate administration services for individuals, pension, and profit-sha ring; and employee benefit plan administration for corporations. In addition, it holds an insurance agency that specializes in selling and servicing group health care policies; operates as an investment adviser that advises the company?s proprietary mutual funds; provides administrative and recordkeeping services for complex retirement plans; and holds a real estate investment trust. The company operates in Warren, Washington, Saratoga, Essex, and Clinton counties and surrounding areas. It owns 28 branch offices and leases 6 offices. The company was founded in 1851 and is headquartered in Glens Falls, New York.

Advisors’ Opinion:

  • [By Rich Duprey]

    Flying straight as an arrow, multi-bank holding company Arrow Financial  (NASDAQ: AROW  )  said yesterday it will pay a regular quarterly dividend of $0.25 per share on June 14 to the holders of record at the close of business on June 3. This is the same pay it has made quarter in, quarter out for the last five years. 

5 Best High Tech Stocks To Watch Right Now: Luminex Corporation(LMNX)

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company?s xMAP technology is used in various segments of the life sciences industry, such as the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, food safety, and biomedical research. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGP IX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment?s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company?s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company was founded in 1995 and is headquartered in Austin, Texas.

Advisors’ Opinion:

  • [By Seth Jayson]

    Basic guidelines
    In this series, I examine inventory using a simple rule of thumb: Inventory increases ought to roughly parallel revenue increases. If inventory bloats more quickly than sales grow, this might be a sign that expected sales haven’t materialized. Is the current inventory situation at Luminex (Nasdaq: LMNX  ) out of line? To figure that out, start by comparing the company’s inventory growth to sales growth. How is Luminex doing by this quick checkup? At first glance, not so great. Trailing-12-month revenue increased 9.1%, and inventory increased 32.2%. Comparing the latest quarter to the prior-year quarter, the story looks potentially problematic. Revenue grew 9.2%, and inventory grew 32.2%. Over the sequential quarterly period, the trend looks worrisome. Revenue dropped 4.2%, and inventory grew 8.0%.

  • [By Markus Aarnio]

    Illumina’s competitors include Affymetrix (AFFX), Life Technologies Corporation (LIFE) and Luminex Corporation (LMNX). Here is a table comparing these companies.

  • [By Sean Williams]

    Now what: Normally, a $5 million haircut isn’t a big deal. However, if a company is losing money and that $5 million is a clean 14% below its original forecasts, then it’s certainly going to garner a negative reaction. It also doesn’t help that Natural Molecular Testing Corporation — that aforementioned “large customer” — recently entered in a multi-year collaboration with Luminex (NASDAQ: LMNX  ) earlier this month, casting a gray cloud over GenMark’s future revenue stream with NMTC. Until we get better visibility from GenMark’s management team and see the company moving toward profitability, this is a name I’d suggest keeping your distance from.

  • [By Seth Jayson]

    There’s no foolproof way to know the future for Luminex (Nasdaq: LMNX  ) or any other company. However, certain clues may help you see potential stumbles before they happen — and before your stock craters as a result.

5 Best High Tech Stocks To Watch Right Now: HealthStream Inc (HSTM)

HealthStream, Inc. (HealthStream), incorporated in September 27, 1990, provides Internet-based learning and research solutions for healthcare organizations. The Company’s learning products are used by healthcare organizations to meet a range of their training, certification, and development needs, while its research products provide the customers information about patients’ experiences, workforce engagement, physician relations, and community perceptions of their services. HealthStream’s products and services are organized into two segments: HealthStream Learning and HealthStream Research. HealthStream’s customers include healthcare organizations, pharmaceutical and medical device companies, and other participants in the healthcare industry. Its customer base across both learning and research business units includes over 3,000 healthcare organizations (predominately acute-care facilities) throughout all 50 states of the United States. In March 2014, the Company acq uired Health Care Compliance Strategies, Inc., a Jericho, New York-based company focused on interactive and engaging online compliance training for healthcare organizations.

The Company’s core learning product is the HealthStream Learning Center (HLC), its learning platform provided through the Internet through software-as-a-service (SaaS) model. As of December 31, 2012, HealthStream had approximately 3.1 million contracted, primarily hospital-based subscribers, to the HLC platform. It delivers educational and training courseware to its customers through the HLC platform. Its research products and service offerings include satisfaction surveys, data analyses of survey results, and other research-based measurement tools focused on patients, physicians, employees, and members of the community. The Company’s core research product is the Patient Insights survey.

HealthStream Learning & Talent Management

Within HealthStream Learning & Ta lent Management, the Company brings training, assessment and! education content together with administrative and management tools through its HLC , HCC, and HPC. It also offers a more streamlined version of the HLC, HealthStream Express, along with HealthStream Connect, a content delivery platform that is designed for the singular purpose of allowing access to its content libraries. These content libraries allow HLC platform customers to subscribe to an array of additional courseware. Additionally, through its Hospital Direct capability in the HLC, medical device companies can offer online training support for their products and sponsor continuing education directly to healthcare workers.

The Company’s learning management system supports healthcare administrators in configuring training to meet the needs of various groups of employees, modifying training materials, and documenting training completion. It offer training, implementation, and account management services to facilitate adoption of its platform. Offered via a SaaS model, its Internet-based platform and its courseware are hosted in a central data center that allows authorized subscribers Internet access to its services.

In addition to the HLC, the Company offers an array of platform extensions, each serving a function for hospitals and health systems. The Authoring Center is a platform extension that provides healthcare organizations the capability to create Internet-based courses by moving their existing course material online or self-authoring new material and electively sharing these materials with its other customers through a courseware exchange. It also offers Authoring Pro, an upgraded product, which includes a licensed image library, as an additional subscription to this product. The HealthStream Competency Center (HCC) is its SaaS-based platform extension for competency management solution for healthcare organizations, provides customers tools to assess competency and appraise performance.

SimCe nter, the Company’s platform extension offer products and ! services ! focused on accelerating the global adoption of simulation-based learning by healthcare providers with a focus on improving clinical competencies and patient outcomes. The new venture offers healthcare organizations and medical and nursing schools worldwide a range of integrated SaaS applications that accelerate development and distribution of simulation content; enable enterprise-wide management of simulation centers, simulators, and programs, and support assessment of the effectiveness of simulation training as part of complete curricula.

The HealthStream Improvement Center is a SaaS-based platform extension related to its research offering. This extension is an online system for hospital leaders to optimize and accelerate the execution of improvement plans, including those based on results from its patient, employee, physician, and community surveys. The Improvement Center, a licensed technology, is one of a number of solutions from HealthStream Research that include a line of survey products, national benchmarks, HCAHPS Improvement Library, consulting services, and other support tools.

HealthStream Research

HealthStream Research complements HealthStream Learning’s product and service offerings by providing hospital-based customers with Patient Insights, Employee Insights, Physician Insights, and Community Insights surveys, data analyses of survey results, and other research-based measurement tools. Its services are designed to provide thorough analyses that provide insightful recommendations for change; benchmarking capability using its databases, and consulting services to identify solutions for its customers based on their survey results. Its survey and research solutions focus on providing valid data to assist its customers. In addition to collecting and reporting data, the Company provides analysis and consulting to help customers understand their survey results and the underlying impact on their business. It is with this insight that healthcare organizati! ons are a! ble to develop plans for improved performance that can be delivered through its learning solutions.

The Company competes with Cornerstone OnDemand, Healthcare Source, Oracle, SABA, SAP, SumTotal Systems, Avatar International, Gallup, National Research Corporation, Press Ganey Associates, Professional Research Consultants, Inc., Kenexa, Foresight, B-Line Medical, CAE/Meti, and EMS

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on Healthstream (Nasdaq: HSTM  ) , whose recent revenue and earnings are plotted below.

  • [By Sean Williams]

    What: Shares of HealthStream (NASDAQ: HSTM  ) , an Internet-based talent management company that provides learning solutions to the health care industry, jumped as much as 16% after the company reported its second-quarter earnings results.

5 Best High Tech Stocks To Watch Right Now: Compania Cervecerias Unidas S.A. (CCU)

Compañia Cervecerias Unidas S.A., through its subsidiaries, produces, bottles, sells, and distributes beverages primarily in Chile, Argentina, and Uruguay. It offers super-premium, premium, medium-priced, and popular-priced brands of alcoholic and non-alcoholic beer under 12 proprietary brands and 4 licensed brands, such as Royal Guard; Royal Light; Heineken; Budweiser; Paulaner; Austral; Kunstmann; D’olbek; Cristal; Cristal Cero 0°; Cristal Black Lager; Cristal Light; Escudo; Morenita; Lemon Stones; and Dorada brands. The company also produces and markets ultra-premium, reserve, varietal, and popular-priced wines under the brand families comprising Viña San Pedro Tarapacá, Viña Santa Helena, Viña Misiones de Rengo, Viña Mar, Viña Altaïr, Bodega Tamarí, Finca la Celia, and Viña Leyda. In addition, it offers cider and spirits under the brand names of Real, La Victoria, Saenz Briones 1888, and El Abuelo; pisco, rum, and ready-to-drink cocktails under the Control C , Mistral, Campanario, Sierra Morena, Pisco Bauzá and Havana Club, Chivas Regal, and Absolut Vodka brand names; and home-made sweet snacks products under the Calaf, Natur, and Nutrabien brand names. Further, the company produces and sells tea; sports and energy drinks; carbonated beverages, including cola and non-cola, as well as non carbonated beverages; fruit juices; mineral water, sparkling and still water, purified water, and home and office delivery water products; and nectars. It serves small and medium sized retail outlets; retail establishments, such as restaurants, hotels, and bars for on-premise consumption; wholesalers; and supermarket chains. Compañia Cervecerias Unidas S.A. also exports its products to Europe, Latin America, the United States, Canada, and others. The company was founded in 1850 and is based in Santiago, Chile. Compañia Cervecerias Unidas S.A. is a subsidiary of Inversiones y Rentas S.A.

Advisors’ Opinion:

  • [By Patricio Kehoe] s largest brewer (with about 80% of the market’s share) and No. 2 in the Argentine market, behind Quilmes, which owns 75% of that market. With investment gurus Jim Simons (Trades, Portfolio) and Manning & Napier Advisors buying the company’s shares this past quarter, I believe this company’s business model is worth a deeper look.

    Running the Market

    As the only brewer in Chile with a nationwide distribution network, United Breweries benefits from significant economies of scale, in addition to its brand power. The company’s product portfolio not only features the Cristal beer brand, but also includes wine, spirits and company-owned non-alcoholic beverages. In addition to this, the firm benefits from licenses to sell PepsiCo Inc. (PEP) and Heineken beverages, while also importing Anheuser Busch Inbev SA (ADR) (BUD)’s Budweiser beer to Chile and Argentina. This strong market position has allowed the firm to generate excess returns on invested capital above 20%, making it an attractive investment.

    Furthermore, United Breweries’ business model is focused on market expansion, and in 2013 the company raised 15% of its market capital (CLP 340 billion) in order to fun acquisitions in Paraguay and Argentina. This latter country has been particularly endorsing the firm’s growth, boosting 2006’s 16% market share to 23% in 2012. This raise is probably due to the CLP 27 billion that the brewer spent on capital expenditures in Argentina. Looking forward, the company is set on expanding its core businesses by targeting the non-alcoholic Argentine market, the Chilean snack and dairy industry, as well as expanding into nearby markets of Peru, Uruguay, Colombia or Ecuador. And although the risk of an overpayment for acquisitions remains, I believe the company’s cost advantage in serving the Southern region of Chile will allow for margins to stay intact.

    Valuation and Risks

    Nevertheless, United Breweries’ market dominance in Chile t

  • [By fedezaldua]

    After a couple of capital increases and what looks like a weak strategy for its growth in different South American countries, Chile's beer king Compania Cervecerias Unidas (CCU) – most commonly knows as CCU – is selling at a steep discount to its peers. In other words, being down by 23% year to date, I think it might be the time to start thinking of buying CCU's shares.